PT  - JOURNAL ARTICLE
AU  - Bing Liu
AU  - Junyan Han
AU  - Xiaohuan Cheng
AU  - Long Yu
AU  - Li Zhang
AU  - Wei Wang
AU  - Lan Ni
AU  - Chaojie Wei
AU  - Yafei Huang
AU  - Zhenshun Cheng
TI  - Persistent SARS-CoV-2 presence is companied with defects in adaptive immune system in non-severe COVID-19 patients
AID  - 10.1101/2020.03.26.20044768
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.26.20044768
4099  - http://medrxiv.org/content/early/2020/03/30/2020.03.26.20044768.short
4100  - http://medrxiv.org/content/early/2020/03/30/2020.03.26.20044768.full
AB  - Background COVID-19 has been widely spreading. We aim to examine adaptive immune cells in non-severe patients with persistent SARS-CoV-2 shedding.Methods 37 non-severe patients with persistent SARS-CoV-2 presence transferred to Zhongnan hospital of Wuhan University were retrospectively recruited to PP (persistently positive) group, which was further allocated to PPP group (n=19) and PPN group (n=18), according to their testing results after 7 days (N=negative). Epidemiological, demographic, clinical and laboratory data were collected and analyzed. Data from age- and sex-matched non-severe patients at disease onset (PA [positive on admission] patients, n=37), and lymphocyte subpopulation measurements from matched 54 healthy subjects were extracted for comparison.Results Compared with PA patients, PP patients had much improved laboratory findings, including WBCs, neutrophils, lymphocytes, neutrophil-to-lymphocyte ratio, albumin, AST, CRP, SAA, and IL-6. The absolute numbers of CD3+ T cells, CD4+ T cells, and NK cells were significantly higher in PP group than that in PA group, and were comparable to that in healthy controls. PPP subgroup had markedly reduced B cells and T cells compared to PPN group and healthy subjects. Finally, paired results of these lymphocyte subpopulations from 10 PPN patients demonstrated that the number of T cells and B cells significantly increased when the SARS-CoV-2 tests turned negative.Conclusion Persistent SARS-CoV-2 presence in non-severe COVID-19 patients is associated with reduced numbers of adaptive immune cells. Monitoring lymphocyte subpopulations could be clinically meaningful in identifying fully recovered COVID-19 patients.Summary Defects in adaptive immune system, including reduced T cells and B cells, were frequently observed in non-severe COVID-19 patients with persistent SARS-CoV-2 shedding. Assessment of immune system could be clinically relevant for discharge management.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Natural Science Foundation of China (2017NSFC81670825 to Y.H. and 2020NSFC31970865 to J.H.), Natural Science Foundation of Hubei Province (2017CFB512 to B.L.), and Science and Technology Innovation Cultivation Foundation of Zhongnan Hospital of Wuhan University (ZNPY2018107 to B.L.).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAfter publication, the data will be made available to others on reasonable requests to the corresponding author. A proposal with detailed description of study objectives and statistical analysis plan will be needed for evaluation of the reasonability of requests. Additional materials might also be required during the process of evaluation. Deidentified participant data will be provided after approval from the corresponding author and Zhongnan Hospital of Wuhan University.COVID-19Coronavirus disease 2019SARS-CoV-2Severe acute respiratory syndrome coronavirus 2HCHealthy controls